Vera Therapeutics Inc Cl A (VERA-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr06/2024	Next Qtr09/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	-0.57	-0.59	-2.32	-2.54
Number of Estimates	6	6	7	6
High Estimate	-0.52	-0.54	-2.17	-2.15
Low Estimate	-0.67	-0.69	-2.62	-3.31
Prior Year	-0.46	-0.45	-2.25	-2.32
Growth Rate Est. (year over year)	-23.91%	-31.11%	-3.11%	-9.48%

Earnings History - Surprises*

	Qtr Ending03/2024	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023
Reported	$-0.56	$-0.58	$-0.45	$-0.46
Estimate	$-0.53	$-0.53	$-0.50	$-0.69
Difference	-0.03	-0.05	+0.05	+0.23
Surprise	-5.66%	-9.43%	+10.00%	+33.33%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.80

3 Mths Ago10

4.78

2 Mths Ago9

4.78

1 Mth Ago9

4.78

Current9

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	10	9	9	9
	9	8	8	8
Holds	1	1	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

number cruncher

U.S technology stocks with earnings and price momentum

Lightspeed Commerce stock soars on better-than-expected profit forecast

GameStop, AMC continue to slide as meme stocks rally loses steam

The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings

Proxy advisers recommend investors vote ‘no’ on Shopify executive pay

The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets

Chevron tops Tesla as most-shorted stock in April, says Hazeltree

The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day